grantGrants.gov

Mood and Psychosis Symptoms during the Menopause Transition (R21 Clinical Trial Optional)

Organization National Institutes of HealthPosted 22 Nov 2024Deadline 7 Jan 2028
HHS-NIH1193.24293.313synopsis
Sign up free to applyFree account · Full description · Apply link · All opportunity types

Full Description

Opportunity Number: PAR-25-282 Document Type: synopsis CFDA Numbers: 93.242, 93.313

Read the full description

Sign up freeFree account · No credit card required
Mood and Psychosis Symptoms during the Menopause Transition (R21 Clinical Trial Optional) — National Institutes of Health | Dev Procure